The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEntain Regulatory News (ENT)

Share Price Information for Entain (ENT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 809.20
Bid: 814.00
Ask: 814.40
Change: -9.60 (-1.17%)
Spread: 0.40 (0.049%)
Open: 812.80
High: 823.20
Low: 808.60
Prev. Close: 818.80
ENT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - ENTAIN PLC

19 Jan 2021 12:49

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

Barclays PLC.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

ENTAIN PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

18 January 2021

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

YES: MGM RESORTS INTERNATIONAL

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:EUR 0.01 ordinary
InterestsShort Positions
Number(%)Number(%)

(1)

Relevant securities owned
and/or controlled:

6,534,443

1.12%

1,499,916

0.26%

 

 

 

 

(2)

Cash-settled derivatives:

 

 

 

 

2,629,078

0.45%

5,226,830

0.89%

 

 

 

 

(3)

Stock-settled derivatives (including options)

 

 

 

 

and agreements to purchase/sell:

0

0.00%

0

0.00%

 

 

 

 

 

 

 

 

TOTAL:

9,163,521

1.57%

6,726,746

1.15%

 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevantPurchase/saleNumber ofPrice per unit
securitysecurities
EUR 0.01 ordinaryPurchase

196

14.1321 GBP
EUR 0.01 ordinaryPurchase

510

13.9850 GBP
EUR 0.01 ordinaryPurchase

746

14.1195 GBP
EUR 0.01 ordinaryPurchase

1,390

14.1608 GBP
EUR 0.01 ordinaryPurchase

2,560

14.1314 GBP
EUR 0.01 ordinaryPurchase

9,153

14.1261 GBP
EUR 0.01 ordinaryPurchase

19,053

14.1350 GBP
EUR 0.01 ordinaryPurchase

23,045

14.1278 GBP
EUR 0.01 ordinaryPurchase

82,706

14.1206 GBP
EUR 0.01 ordinaryPurchase

109,047

14.1349 GBP
EUR 0.01 ordinarySale

168

14.0769 GBP
EUR 0.01 ordinarySale

223

14.1305 GBP
EUR 0.01 ordinarySale

344

13.9850 GBP
EUR 0.01 ordinarySale

423

14.1354 GBP
EUR 0.01 ordinarySale

442

14.1250 GBP
EUR 0.01 ordinarySale

445

14.1401 GBP
EUR 0.01 ordinarySale

742

14.1200 GBP
EUR 0.01 ordinarySale

1,920

14.0321 GBP
EUR 0.01 ordinarySale

1,988

14.1352 GBP
EUR 0.01 ordinarySale

2,181

14.0925 GBP
EUR 0.01 ordinarySale

3,331

14.1113 GBP
EUR 0.01 ordinarySale

3,391

14.1361 GBP
EUR 0.01 ordinarySale

5,723

14.1329 GBP
EUR 0.01 ordinarySale

20,547

14.1357 GBP
EUR 0.01 ordinarySale

21,318

14.1350 GBP
EUR 0.01 ordinarySale

32,821

14.1463 GBP
EUR 0.01 ordinarySale

165,405

14.1330 GBP
 
(b)Cash-settled derivative transactions
Class ofProductNature of dealingNumber ofPrice per
relevantdescriptionreferenceunit
securitysecurities
EUR 0.01 ordinaryCFDLong

129

14.0687 GBP
EUR 0.01 ordinaryCFDLong

168

14.0769 GBP
EUR 0.01 ordinarySWAPLong

180

14.0696 GBP
EUR 0.01 ordinarySWAPLong

183

14.1077 GBP
EUR 0.01 ordinarySWAPLong

423

14.1354 GBP
EUR 0.01 ordinarySWAPLong

791

14.1312 GBP
EUR 0.01 ordinaryCFDLong

1,419

14.0381 GBP
EUR 0.01 ordinarySWAPLong

1,803

14.1214 GBP
EUR 0.01 ordinarySWAPLong

2,436

14.0860 GBP
EUR 0.01 ordinarySWAPLong

5,422

14.0804 GBP
EUR 0.01 ordinarySWAPLong

5,723

14.1329 GBP
EUR 0.01 ordinaryCFDLong

28,110

14.1338 GBP
EUR 0.01 ordinarySWAPLong

30,977

14.1310 GBP
EUR 0.01 ordinaryCFDShort

129

14.1362 GBP
EUR 0.01 ordinarySWAPShort

183

14.1310 GBP
EUR 0.01 ordinarySWAPShort

1,370

14.0739 GBP
EUR 0.01 ordinarySWAPShort

1,557

14.0599 GBP
EUR 0.01 ordinarySWAPShort

2,930

14.1328 GBP
EUR 0.01 ordinarySWAPShort

5,237

14.0715 GBP
EUR 0.01 ordinaryCFDShort

9,153

14.1261 GBP
EUR 0.01 ordinaryCFDShort

10,181

14.1556 GBP
EUR 0.01 ordinarySWAPShort

28,205

14.1349 GBP
EUR 0.01 ordinarySWAPShort

40,733

14.1099 GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

19 Jan 2021

Contact name:

Large Holdings Regulatory Operations

Telephone number*:

020 3134 7213

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210119005579/en/

Copyright Business Wire 2021

Date   Source Headline
24th Apr 202412:09 pmRNSResult of AGM
17th Apr 20247:00 amRNSQ1 Trading Update
16th Apr 20249:17 amRNSTR1: Notification of Major Holdings
4th Apr 20247:00 amRNSChairman Succession
2nd Apr 20247:00 amRNSBlock Listing Six Monthly Return
2nd Apr 20247:00 amRNSTotal Voting Rights
22nd Mar 20247:42 amRNSAnnual Report, AGM and Gender Pay Gap Report
12th Mar 202411:41 amRNSDirector/PDMR Shareholding
12th Mar 202410:00 amRNSBoard Appointment
11th Mar 20241:54 pmRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSFY23 results in line with expectations
1st Mar 20247:00 amRNSTotal Voting Rights
19th Feb 20247:00 amRNSTR1: Notification of Major Holdings
8th Feb 20242:00 pmRNSBETMGM FY23 UPDATE
6th Feb 20242:00 pmRNSNotice of BetMGM FY 2023 update
2nd Feb 20244:11 pmRNSNew Board Committee
1st Feb 20247:00 amRNSTotal Voting Rights
3rd Jan 20249:27 amRNSTR1: Notification of Major Holdings
3rd Jan 20247:00 amRNSBoard Appointment
2nd Jan 20248:29 amRNSTotal Voting Rights
15th Dec 20234:00 pmRNSBoard Committee Changes
13th Dec 20237:00 amRNSDirectorate Change
6th Dec 202310:00 amRNSDirector/PDMR Shareholding
6th Dec 20237:00 amRNSBetMGM at Morgan Stanley Consumer Conference
5th Dec 20232:06 pmRNSFinal Approval of Deferred Prosecution Agreement
4th Dec 20232:00 pmRNSBetMGM Business Update
1st Dec 20237:00 amRNSTotal Voting Rights
30th Nov 202310:42 amRNSStatement regarding KSA decisions
27th Nov 20232:00 pmRNSBetMGM Business Update Event Details
24th Nov 20232:01 pmRNSUpdate on Deferred Prosecution Agreement
15th Nov 202311:00 amRNSDirector/PDMR Shareholding
8th Nov 20232:00 pmRNSTR1: Notification of Major Holdings
8th Nov 20237:00 amRNSDirector/PDMR Shareholding
7th Nov 20233:39 pmRNSTR1: Notification of Major Holdings
6th Nov 20239:12 amRNSTR1: Notification of Major Holdings
2nd Nov 20237:00 amRNSQ3 Trading Statement & Business Update
1st Nov 20237:00 amRNSTotal Voting Rights
31st Oct 20237:00 amRNSBoard Appointment
4th Oct 20232:00 pmRNSNotice of BETMGM Business Update Event
4th Oct 202311:30 amRNSTR1: Notification of Major Holdings
2nd Oct 202312:35 pmRNSBlock Listing Six Monthly Return
2nd Oct 20239:11 amRNSTotal Voting Rights
2nd Oct 20237:00 amRNSCompletion of acquisition of Angstrom Sports
25th Sep 20237:00 amRNSUpdate on current trading and operational strategy
5th Sep 20232:00 pmRNSBetMGM participate in Bank of America Conference
1st Sep 202310:02 amRNSTotal Voting Rights
21st Aug 20235:15 pmRNSResult of tender offer to shareholders of STS
10th Aug 20237:01 amRNSUpdate on HMRC Investigation
10th Aug 20237:00 amRNSInterim Results
1st Aug 20238:21 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.